MD MEDNAX Inc.

MEDNAX Radiology and vRad to Exhibit at AHRA 2017 Annual Meeting

MEDNAX Radiology and vRad (Virtual Radiologic), a MEDNAX company, will exhibit at AHRA: The Association for Medical Imaging Management’s 45th Annual Meeting from July 10-12 at the Anaheim Convention Center in Anaheim, Calif. vRad leadership will be on-site at Booth #633. Through an integrated team of physicians practicing “in the zone” with every patient interaction, MEDNAX Radiology and vRad deliver seamless on-the-ground and cloud radiology, providing scale and value to hospitals, clinics, imaging centers and referring physicians nationwide.

AHRA is the professional organization representing management at all levels of hospital imaging departments, freestanding imaging centers and group practices with 5,000 members worldwide. AHRA offers a complete slate of professional development programs, including a comprehensive selection of educational conferences and seminars, networking opportunities, award winning publications, and the Certified Radiology Administrator (CRA) credential.

Founded in 1979, MEDNAX is a physician-led, national health solutions partner with 3,725+ affiliated physicians and over 300 practices serving 3,000+ hospitals nationwide. vRad, the nation’s leading radiology physician services and telemedicine company, joined MEDNAX in 2015, broadening the Company’s scope of services to meet the needs of the health care community through its 500+ affiliated U.S. board certified and eligible physicians.

Through the collective efforts of MEDNAX Radiology and vRad, MEDNAX is proud to be recognized as a leader in radiology, an innovator in health care informatics and a pioneer in telemedicine. By combining on-site radiology excellence with a world-class technology platform, MEDNAX offers on-demand clinical capacity with subspecialty care; cost efficiency through scale; productivity optimization through patented technology and workflow innovation; operational excellence leveraging data analytics, and growth through proven sales and marketing resources.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,725 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a management services company and a consulting services company. Additional information is available at www.mednax.com.

ABOUT vRad

vRad (Virtual Radiologic) is the leading national teleradiology services and telemedicine company with 500+ U.S. board-certified and eligible physicians, over 75% of whom are subspecialty trained. Its clinical expertise and evidence-based insight help clients make decisions about the health of their patients and their imaging services. vRad is a MEDNAX company, a national health solutions partner specializing in neonatal and other pediatric services, anesthesia, radiology, pediatric cardiology and other physician and management services. vRad interprets and processes patient imaging studies on the world’s largest and most advanced picture archiving and communication system (PACS) for over 2,100 client hospitals, health systems and radiology groups in all 50 states. The company has 17 issued patents for innovation in telemedicine workflow and is a recognized leader in imaging analytics and deep learning-assisted diagnostics. vRad is also a past winner of Frost & Sullivan’s Visionary Innovation Award for Medical Imaging Analytics (North America). For more information, please visit www.vrad.com. Follow us on Twitter, Facebook and LinkedIn.

EN
10/07/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 27,600 shares at 15.350USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch